Skip to content
Review Open access

Dysregulation of Calcium Signaling Homeostasis in the Onset and Progression of Alzheimer's Disease and Its Therapeutic Potential

Oct 2026 · Nature Cell and Science · 0 citations · 50 references

TL;DR

The physiological roles of calcium signaling homeostasis in neuronal function, the manifestations and mechanisms of calcium dyshomeostasis in AD, the impact of abnormal calcium signaling on cognition and neuronal network function, and the therapeutic potential and drug development progress of calcium channel–related targets are reviewed.

Abstract

Alzheimer's disease (AD), the most common neurodegenerative disorder, accounts for 60–70% of all dementia cases and is clinically characterized by progressive memory impairment, executive dysfunction, and neuropsychiatric symptoms. The traditional pathogenic framework has focused on β-amyloid (Aβ) deposition and Tau neurofibrillary tangles; however, recent trials of Aβ-targeting monoclonal antibodies (e.g., aducanumab, lecanemab) have shown that plaque reduction does not consistently translate into robust neurocognitive benefit, suggesting that AD pathogenesis extends far beyond protein aggregation alone. The "calcium hypothesis" posits that Aβ and Tau aggregation represent downstream events, whereas disruption of neuronal calcium homeostasis is an upstream driver that may precede overt pathology. Disturbances in calcium signaling act as a central hub linking proteinopathy, synaptic dysfunction, neuronal hyperexcitability, glial activation, vascular dysregulation, and metabolic failure. Dysregulated calcium homeostasis in AD encompasses coordinated abnormalities at the level of membrane channels (e.g., L-type voltage-gated calcium channels [L-VGCCs], TRPC family), endoplasmic reticulum (ER; ryanodine receptors [RyRs]), mitochondria, lysosomes, and glial cells, thereby coupling protein pathology to synaptic failure, energy deficits, neuroinflammation, and impaired cerebral perfusion. Notably, all currently approved symptomatic AD treatments — including the noncompetitive NMDA receptor antagonist memantine and acetylcholinesterase inhibitors — impinge on calcium signaling pathways. Emerging agents targeting RyRs (e.g., dantrolene, S107), TRPC3 antagonists (Pyr3, Pyr10), and lysosomal calcium channel inhibitors (e.g., Ned-19) have also demonstrated therapeutic potential in preclinical models. Here, we systematically review (i) the physiological roles of calcium signaling homeostasis in neuronal function, (ii) the manifestations and mechanisms of calcium dyshomeostasis in AD, (iii) the impact of abnormal calcium signaling on cognition and neuronal network function, and (iv) the therapeutic potential and drug development progress of calcium channel–related targets. We further discuss the challenges and prospects of cross-channel network analysis and genotype-informed combination strategies, with the goal of providing a theoretical foundation for calcium homeostasis–targeted therapies in AD.

Read PDF

Similar papers

Review Sep 2026

Crosstalk and Convergence in Alzheimer's Disease: Integrating Brain Injury, Neuroinflammation, and Precision Medicine for Next-Generation Therapeutics.

This review proposes conceptualizing Alzheimer's disease as a neural circuit disorder that emerges from sustained crosstalk among multiple interacting pathways, including brain injury, neuroinflammation, mitochondrial and metabolic dysfunction, neurovascular dysfunction, neurovascular dysfunction, synaptic dysfunction,...

Desh Deepak Singh · 0 citations
Review Open access Oct 2026

The Role of Amyloid-Beta Plaques in Disrupting Neural Communication in Alzheimer’s Disease

Alzheimer’s Disease (AD) is defined as a particular onset and course of cognitive and functional decline. Central to AD pathology is the abnormal processing of amyloid precursor proteins (APPs), which produces amyloid-beta (Aβ) peptides prone to misfolding and aggregation. Soluble Aβ oligomers are now also recognized a...

Aditya Reddy · 0 citations
Open access 2026

Mitochondrial Calcium Dysregulation: A Central Nexus in Alzheimer’s Disease Pathogenesis and Therapeutic Intervention

The roles of mitochondrial calcium uniporter (MCU) complex and mitochondrial sodium – calcium – lithium exchanger (NCLX) in regulating mitochondrial Ca²⁺ along with the therapeutic effects of regulating mitochondrial Ca²⁺ in the brain are highlighted.

S. Saha · 0 citations
Review Open access Sep 2026

Mechanisms of Brain Aging and Their Links to Alzheimer’s and Parkinson’s Disease Pathology

Brain aging is a major risk factor for neurodegenerative disorders and is associated with a progressive loss of neuronal homeostasis. Rather than resulting from a single pathological event, brain aging involves coordinated changes across multiple biological processes, including neuroinflammation, proteostasis impairmen...

Hai-Yi Yi, Hai-Meng Qin, J. Goon et al. · 0 citations
Review Nov 2026

Molecular mechanisms of lithium neuroprotection in Alzheimer's disease: A systematic comprehensive review.

Alzheimer's disease (AD) contributes to most cases of dementia globally and is characterized by amyloid-β (Aβ) deposition, tau hyperphosphorylation, oxidative stress, and neuroinflammation. Existing treatments are merely management products that do not alter the course of the disease; thus, there is an urgent need to d...

Meesala Krishna Murthy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.